The CC genotype of the CRY2 rs1401417 SNP was also associated with the risk of developing diffuse large B-cell lymphoma (DLBCL) and T-cell lymphoma, but no CRY2 SNPs were significantly associated with risk of developing marginal zone B-cell lymphoma (MZBL) [54]. This evidence concerns the gene CRY2 and T-cell non-Hodgkin lymphoma.